Accel Diagnostics
Houston · Founded 2012
About Accel Diagnostics
Accel Diagnostics is developing a lab-on-chip protein diagnostic platform that enables inexpensive, disposable, credit-card sized devices to be used for the rapid diagnosis of infectious and chronic diseases at the point-of-care. pScreen™’s ability to deliver an accurate diagnosis within 30 minutes results in a higher quality of care at a significantly lower cost. Accel’s solution marks a paradigm shift in the management of congestive heart failure (CHF). For the first time, it allows CHF patients to frequently monitor their level of heart distress outside the clinical setting and in the comfort of their home. Accel’s solution enables patients and their physicians to respond before physical symptoms occur, preventing otherwise frequent life threatening events and costly reoccurring hospitalizations.
Company Facts
- Founded: 2012
- Legal name: Accel Diagnostics, LLC.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $25.0K
- Funding stage: Seed
- Last round: Convertible Note (May 2016)
- Website: acceldx.com
- Phone: +1 713-242-8658
Social Profiles
Canonical: https://fsome.com/organization/accel-diagnostics-8378581 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.